June 16, 2023
Bulletin interne de l'Institut Pasteur
The Plasmodium RNA Biology laboratory (024819), led by Sebastian Baumgarten, came to the end of its term and was closed on May 31, 2023.
In June 2022, following the favorable opinion issued by the Scientific Council in October 2022, the Board of Governors approved the proposal by the President to establish the Parasite RNA biology (Biologie des ARN des parasites) junior group (G5) as from June 1, 2023.
This junior group will be part of the Parasites and Insect Vectors Department and will be directed by Sebastian Baumgarten, a Research Associate at the Institut Pasteur.
More information in decision memo 1311
Efforts to modernize the approval and signing process for contractual documents have moved up a gear since the COVID-19 pandemic, when a new approach was needed during the periods of lockdown. Since the pandemic, the Institut Pasteur has used the electronic DocuSign system to approve and sign most of its contractual documents.
A procedure has been drawn up to clarify the approval and signing process for contractual documents, with the aim of continuing to use DocuSign on a long-term basis. The purpose of the procedure is to:
- determine the scope;
- set out the different methods for approving and signing contractual documents;
- provide details about conditions in which DocuSign can be used, if necessary.
We all have a responsibility to comply with this procedure to ensure the successful modernization of the approval and signing process for contractual documents and secure the Institut Pasteur's interests.